Swiss National Bank’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-209,660
Closed -$1.86M 2697
2022
Q3
$1.86M Hold
209,660
﹤0.01% 1924
2022
Q2
$2.65M Sell
209,660
-1,100
-0.5% -$14K ﹤0.01% 1721
2022
Q1
$3.99M Buy
210,760
+28,900
+16% +$736K ﹤0.01% 1586
2021
Q4
$6.38M Hold
181,860
﹤0.01% 1300
2021
Q3
$6.66M Buy
181,860
+37,173
+26% +$1.46M ﹤0.01% 1257
2021
Q2
$5.68M Buy
144,687
+2,600
+2% +$75.1K ﹤0.01% 1416
2021
Q1
$4.01M Buy
142,087
+19,300
+16% +$615K ﹤0.01% 1586
2020
Q4
$3.93M Hold
122,787
﹤0.01% 1509
2020
Q3
$3.97M Hold
122,787
﹤0.01% 1324
2020
Q2
$3.39M Hold
122,787
﹤0.01% 1383
2020
Q1
$2.19M Hold
122,787
﹤0.01% 1396
2019
Q4
$3.08M Sell
122,787
-48,800
-28% -$1.07M ﹤0.01% 1473
2019
Q3
$3.07M Buy
171,587
+48,800
+40% +$1.02M ﹤0.01% 1411
2019
Q2
$2.7M Hold
122,787
﹤0.01% 1514
2019
Q1
$3.75M Buy
122,787
+18,500
+18% +$461K ﹤0.01% 1268
2018
Q4
$2.41M Buy
+104,287
New +$3.24M ﹤0.01% 1443

Other funds holding HCM

Swiss National Bank's HCM Position: Q4 2022 in Review

Swiss National Bank sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 209,660 shares — an estimated $1.86M sold.

Swiss National Bank first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $6.66M in Q3 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Swiss National Bank reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Swiss National Bank sold 209,660 HUTCHMED shares in Q4 2022, an estimated $1.86M.
  • Swiss National Bank first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
  • Swiss National Bank's HUTCHMED position peaked at $6.66M in Q3 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.